Copyright © 1994 by the European Society of Cardiology.
© 1994 The European Society of Cardiology
Treatment of recurrent pericarditis with colchicine
From the Division of Cardiology, Hôpital Cardiologique, Centre Hospitalier Régional Universitaire Lille, France
Received 27 May 1993; revised 30 August 1993; .
Correspondence: Dr Alain Millaire, Service de Cardiologie C. Hôpital Cardiologique, Centre Hospitalier Régional Universitaire, Bld du Pr J Leclercq, 59037 Lille Cedex, France
Abstract
Corticosteroid therapy, because of its frequent and severe side effects should be avoided if possible, and colchicine may be an effective substitute in steroid-dependent recurrent pericarditis.
The aim of our study was to assess the usefulness of colchicine in recurrent pericarditis before initiating corticosteroid treatment. Nineteen consecutive patients (10 males, nine females, age 46±7 years) with recurrent pericarditis (two episodes or more) were included in this prospective open-label study. Before the study, the patients suffered a total of 57 episodes of pericarditis (mean=3·0 ± 0·5 episodes. patient–1) despite the use of non-steroidal anti-inflammatory drugs. The mean interval time between the episodes was 7·3±5·3 months. Colchicine was given at a loading dose of 3 mg and a maintenance dose of 1 mg daily (for 1 to 27 months (mean=7·7). During the clinical follow-up, the efficacy was estimated by the occurrence of new episodes of pericarditis and by the need for corticosteroid treatment. No recurrence occurred in 14 out of the 19 patients (74%) during a follow-up of 37·4±6·5 months. In four out of the 19 patients (21%), five recurrences occurred, which resolved without corticosteroids. Follow-up at 23·8±12·7 months was free of further recurrence. Only one patient (5%) had several recurrences and required corticosteroids for chronic rheumatism. Tolerance was good except for two cases of diarrhoea, one case of hypothyroidism due to associated long-term antidiarrhoeal therapy (containing iodine), and one case of mild leucopenia. No side effects required interruption of treatment, and the overall duration of recurrence-free follow-up after treatment with colchicine (32·5±6·9 months) was significantly different from the mean interval time between the different episodes before colchicine (P<0·0001). Thus, colchicine offered a very good benefit/risk ratio in our patients with recurrent pericarditis and could avoid the need for corticosteroid treatment.
Key Words: Recurrent pericarditis • treatment • colchicine • follow-up
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I f. Kuo, G. J Pearson, and S. L Koshman Colchicine for the Primary and Secondary Prevention of Pericarditis: An Update Ann. Pharmacother., December 1, 2009; 43(12): 2075 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Imazio, A. Brucato, R. Trinchero, D. Spodick, and Y. Adler Colchicine for pericarditis: hype or hope? Eur. Heart J., March 1, 2009; 30(5): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Soler-Soler and J. Sagristà-Sauleda CHAPTER 19 Pericardial Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Imazio, M. Bobbio, E. Cecchi, D. Demarie, B. Demichelis, F. Pomari, M. Moratti, G. Gaschino, M. Giammaria, A. Ghisio, et al. Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial Circulation, September 27, 2005; 112(13): 2012 - 2016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Imazio, M. Bobbio, E. Cecchi, D. Demarie, F. Pomari, M. Moratti, A. Ghisio, R. Belli, and R. Trinchero Colchicine as First-Choice Therapy for Recurrent Pericarditis: Results of the CORE (COlchicine for REcurrent pericarditis) Trial Arch Intern Med, September 26, 2005; 165(17): 1987 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Brucato, Y Shinar, G Brambilla, L Robbiolo, G Ferrioli, M C Patrosso, D Zanni, S Penco, E Boiani, A Ghirardello, et al. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients Lupus, September 1, 2005; 14(9): 670 - 674. [Abstract] [PDF]
|
|
|
|
|
|
G. Artom, N. Koren-Morag, D. H. Spodick, A. Brucato, J. Guindo, A. Bayes-de-Luna, G. Brambilla, Y. Finkelstein, B. Granel, A. Bayes-Genis, et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis Eur. Heart J., April 1, 2005; 26(7): 723 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Lange and L. D. Hillis Acute Pericarditis N. Engl. J. Med., November 18, 2004; 351(21): 2195 - 2202. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Soler-Soler, J. Sagrista-Sauleda, and G. Permanyer-Miralda Relapsing pericarditis Heart, November 1, 2004; 90(11): 1364 - 1368. [Full Text] [PDF]
|
|
|
|
|
|
Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur. Heart J., April 1, 2004; 25(7): 587 - 610. [Full Text] [PDF]
|
|
|
|
|
|
D. H. Spodick Intrapericardial treatment of persistent autoreactive pericarditis/myopericarditis and pericardial effusion Eur. Heart J., October 1, 2002; 23(19): 1481 - 1482. [Full Text] [PDF]
|
|
|
|
|
|
Y. Adler, Y. Finkelstein, J. Guindo, A. Rodriguez de la Serna, Y. Shoenfeld, A. Bayes-Genis, A. Sagie, A. Bayes de Luna, and D. H. Spodick Colchicine Treatment for Recurrent Pericarditis : A Decade of Experience Circulation, June 2, 1998; 97(21): 2183 - 2185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Jackson, J. Satterwhite, and E. Roberts Preclinical and Clinical Pharmacology of Efegatran (LY294468) : A Novel Antithrombin for the Treatment of Acute Coronary Syndromes Clinical and Applied Thrombosis/Hemostasis, October 1, 1996; 2(4): 258 - 267. [Abstract] [PDF]
|
|
|
|
|
|
O. Nugue, A. Millaire, H. Porte, P. de Groote, P. Guimier, A. Wurtz, and G. Ducloux Pericardioscopy in the Etiologic Diagnosis of Pericardial Effusion in 141 Consecutive Patients Circulation, October 1, 1996; 94(7): 1635 - 1641. [Abstract] [Full Text]
|
|